Read an analysis on Harrow's Q3 earnings, inventory issues and strategic pivots, with a focus on VEVYE and IHEEZO's potential for recovery in Q4.

NASDAQ:HROW) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsJamie Webb - Director, Communications ...

Health care apps like MyChart, mySugr, GoodRx, and Smoke Free can enhance patient care through accessibility, convenience, ...

Starting Wednesday, when you call 911 in Santa Clara County, your phone call may be referred to what officials are calling ...

To get an online ADHD prescription, you need a telehealth assessment and an official diagnosis. Once you’ve been diagnosed, a ...

Learn more Chewy's fully licensed online pharmacy can help remove the hassle of arranging your pet's meds or treatment and ...

Objectives Although financial interactions between physicians and pharmaceutical and medical device companies could be ...

Planned Parenthood in El Paso opened the doors to its new, expanded facility Tuesday morning at 1061 Chelsea St. The ...

A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy stalwart ...